Tim Fisher Panel Moderator at BIPLA Annual Symposium: Enablement after Amgen

At the upcoming Boston Intellectual Property Law Association Annual Symposium, Pierce Atwood patent counsel Timothy V. Fisher will moderate a panel discussion on Amgen v. Sanofi, where the U.S. Supreme Court applied the enablement requirement of 35 U.S.C. § 112(a) to patent claims directed to antibodies, finding the claims invalid for encompassing more than the original application enabled. 

Panelists Amy Mahan and Matthew Pearson, who worked on opposing sides of the case as it made its way through the courts, will discuss the history of the case, the Supreme Court decision, and the new USPTO examination guidance. They’ll also mix in some behind-the-scenes anecdotes and practical tips.

Please visit BIPLA for registration instructions.

Tim Fisher is a patent attorney and electrical engineer specializing in patent prosecution and counseling for clients of all sizes, from startups to established technology leaders. He regularly works with stakeholders in various technical, legal, and business roles.